XML 58 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Significant Accounting Policies (Details) - USD ($)
1 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Significant Accounting Policies (Details) [Line Items]      
Medicare shared savings revenue   $ 767,744
Revenue to recover costs incurred percentage   100.00%  
Contract liabilities balance   $ 89,425  
Product return allowance   26,839  
Received Payment $ 767,744    
Savings expense $ 388,884    
Federal deposit insurance   250,000  
Insured excess   $ 18,227 279
Percentage of customers accounts receivable billings   47.30%  
Accounts receivable net   $ 165,464 188,503
Net patient services accounts receivable   71,655 83,251
Allowance of doubtful accounts   13,972 $ 13,972
Accounts receivable bill amount   $ 15,498  
Concentration risk, percentage   10.00%  
Original cost and related accumulated depreciation   $ 673,357  
Provider shared savings expense, description     ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees and supersedes the guidance in Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees.
Equity Option [Member]      
Significant Accounting Policies (Details) [Line Items]      
Anti-dilutive securities (in Shares)   3,111,750 3,269,250
Product Revenue [Member]      
Significant Accounting Policies (Details) [Line Items]      
Contract liabilities balance   $ 5,782  
Minimum [Member]      
Significant Accounting Policies (Details) [Line Items]      
Estimated useful lives   5 years  
Maximum [Member]      
Significant Accounting Policies (Details) [Line Items]      
Estimated useful lives   7 years  
Convertible Notes Payable [Member]      
Significant Accounting Policies (Details) [Line Items]      
Anti-dilutive securities (in Shares)   10,298,333 23,210,423
Warrant [Member]      
Significant Accounting Policies (Details) [Line Items]      
Anti-dilutive securities (in Shares)   51,352,986 47,056,293
Unissued [Member]      
Significant Accounting Policies (Details) [Line Items]      
Anti-dilutive securities (in Shares)   400,000 332,500
Common Stock Issuable [Member]      
Significant Accounting Policies (Details) [Line Items]      
Anti-dilutive securities (in Shares)   13,750,000